Listed pharmas’ poor performances in 3rd quarter
It was analyzed listed pharmaceutical companies had poor performances in the 3rd quarter. Their sales were a little above the annual average, and the profitability was weakened compared to the last year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the KOSPI and KOSDAQ lis...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
